• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Johnson & Johnson

< Previous 1 2 3 Next >
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024
October 15, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Reports Q3 2024 Results
October 15, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Stifel 2024 Healthcare Conference
October 10, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Completes Acquisition of V-Wave
October 09, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference
October 04, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces that its Subsidiary, Red River Talc LLC, has Filed a Voluntary Prepackaged Chapter 11 Case to Resolve All Current and Future Ovarian Cancer Talc Claims
September 20, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 05, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson’s Executive Vice President, Chief Human Resources Officer Peter Fasolo to Retire; Kristen Mulholland Named Chief Human Resources Officer, Effective October 1, 2024
August 26, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Acquire V-Wave
August 20, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference
July 29, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
July 23, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2024
July 17, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson reports Q2 2024 results
July 17, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
July 11, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Completes Acquisition of Proteologix, Inc.
June 21, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
June 04, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Completes Acquisition of Shockwave Medical
May 31, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis
May 28, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
May 16, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 08, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
May 01, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
April 22, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
April 16, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
April 16, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
April 08, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Acquire Shockwave Medical
April 05, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ SWAV
Johnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
April 04, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Expands Commitment to Advance Health Equity
April 03, 2024
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Participate in the BofA Securities Health Care Conference
April 02, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 11, 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap